R03BB01 • ipratropium bromide • Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics
Ipratropium bromide is a bronchodilator used for the treatment of chronic obstructive pulmonary disease (COPD) and bronchial asthma. It works by blocking muscarinic receptors, relaxing airway muscles, and improving breathing.
The medication is administered as an aerosol or nebulizer solution, as directed by a doctor. It is important to follow the recommended dose to avoid side effects.
Side effects may include dry mouth, cough, throat irritation, or dizziness. In rare cases, severe allergic reactions or breathing difficulties may occur.
Ipratropium bromide is not recommended for patients with hypersensitivity to this medication or other anticholinergics.
Substance: ipratropium bromide
Date of last drug list: 01-06-2025
Commercial code: W70423001
Concentration: 250mcg / 2ml
Pharmaceutical form: inhalation solution by nebulization
Quantity: 20
Product type: generic
Price: 23.88 RON
Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Manufacturer: VEM ILAÇ SAN. VE TIC. A.S - TURCIA
Holder: CN UNIFARM S.A. - ROMANIA
Number: 926/2024/01
Shelf life: 24 months
Price
Copayment
Patient
23.88 RON
15.50 RON
8.38 RON